Emergent BioSolutions EBS
NYSE EBS
$5.84 -0.20 (-3.23%)
As of: Nov 12, 2026 · 2:09 PM EST

Emergent BioSolutions (EBS) Sales of Property, Plant and Equipment (2012 - 2026)

Updated

Emergent BioSolutions' Sales of Property, Plant and Equipment was $5.4 million in Q3 2026.

Analysis

Emergent BioSolutions (EBS) Sales of Property, Plant and Equipment (2012 - 2026) Analysis & Trends

On a trailing twelve-month basis, Emergent BioSolutions' Sales of Property, Plant and Equipment was $5.6 million through Sep 30, 2026, down 85.5% year-over-year; for FY2025, it was $38.2 million, up 383.5% from FY2024.

  • In earlier years, Sales of Property, Plant and Equipment was $7.9 million in FY2024.
  • The Q3 2026 figure marks the highest quarterly Sales of Property, Plant and Equipment since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -4.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Emergent BioSolutions 309.85 Mn -371.25 Mn 29.20 Mn 5.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 5.40 Mn
Jun 30, 2026 200,000.00
Jun 30, 2025 100,000.00
Mar 31, 2025 38.10 Mn
Dec 31, 2024 300,000.00
Sep 30, 2024 7.60 Mn
Mar 31, 2012 11.77 Mn
API Access

Emergent BioSolutions Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=EBS&period=max&api_key=YOUR_API_KEY